Tobacco Use DisorderNCT07737288
Effect of Teleconsultation Counseling on Smoking Cessation
A study testing Tele-consultation Counseling and Face-to-Face Counseling in people with Tobacco Use Disorder and Nicotine Dependence, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial conducted at Dokuz Eylül University evaluated whether video teleconsultations are as effective as traditional face-to-face clinic visits for helping people quit smoking Over a 6-month period, the study found that while overall quit rates were statistically similar between the two… Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Tobacco Use Disorder, Nicotine Dependence
- What is being tested?
- Tele-consultation Counseling and Face-to-Face Counseling
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 68 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2021to 1 Oct 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Applying to Dokuz Eylul University Department of Family Medicine Smoking Cessation Outpatient Clinic
- Aged 18-55 years
- Owning and being able to use a personal computer or smartphone
- Being literate
- Voluntarily agreeing to participate in the study and providing written informed consent
Who cannot join
- Having communication difficulties or severe cognitive impairments
- Having a psychotic disorder
- Being pregnant or breastfeeding
- Having received smoking cessation treatment within the past 1 year
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Teleconsultation Counseling in Smoking Cessation Treatment on Smoking Cessation Success: A Randomized Controlled Trial
This randomized controlled trial conducted at Dokuz Eylül University evaluated whether video teleconsultations are as effective as traditional face-to-face clinic visits for helping people quit smoking
- Over a 6-month period, the study found that while overall quit rates were statistically similar between the two groups, patients receiving teleconsultation support experienced significantly fewer cigarette cravings and fewer relapses
- Teleconsultation also solved a common problem in smoking cessation: patients missing their follow-up appointments due to travel or time constraints
Read the detailed description
Detailed Description Background \& Purpose of the Study Smoking is a leading cause of preventable diseases and death worldwide
- While many smokers want to quit, they often face barriers to attending regular follow-up appointments at clinics, such as transportation issues, travel costs, child care, and lack of time
- This study was designed to see if teleconsultation (video calling) could remove these barriers and provide an effective alternative to in-person visits for smoking cessation counseling
Who Participated? The study included 65 volunteer adults, aged 18 to 55, who applied to a smoking cessation clinic
- Participants were randomly divided into two groups: 32 people in the teleconsultation group and 33 people in the face-to-face (control) group
How the Study Worked Both groups received the standard of care recommended by the Ministry of Health . Initial Visit: Every participant had their first visit in person. They underwent a physical exam, had their health history taken, and received a prescription for nicotine replacement therapy (15 mg or 25 mg nicotine patches)
. Follow-Up Plan: After setting a "quit date," patients were followed up on day 10, and at months 1, 2, 3, and 6
. The Difference: The intervention group had all their follow-up counseling sessions via video teleconsultation, while the control group was asked to return to the clinic for face-to-face counseling
.
- Conditions
- Tobacco Use Disorder, Nicotine Dependence
- Being tested
- Tele-consultation Counseling, Face-to-Face Counseling
- Keywords
- Teleconsultation, Telemedicine, Video Consultation, Smoking Cessation, Tobacco Dependence, Craving, Treatment Adherence
- Medical subject headings
- Tobacco Use Disorder, Smoking Cessation, Treatment Adherence and Compliance
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Tele-consultation CounselingBehavioural
Video-based teleconsultation counseling sessions focusing on smoking cessation, craving management, relapse prevention, and treatment adherence.
Face-to-Face CounselingBehavioural
Standard clinic-based face-to-face behavioral counseling sessions following the 5A framework and motivational interviewing.
| Study group | Role | What they receive |
|---|---|---|
| Tele-consultation Group | Experimental | Participants in this arm received face-to-face counseling at the baseline visit, followed by 5 video-based teleconsultation sessions (at Day 10, Month 1, Month 2, Month 3, and Month 6). They also received standard pharmacological treatment (transdermal nicotine patches) and behavioral counseling (5A framework and motivational interviewing). Receives: Behavioral: Tele-consultation Counseling |
| Face-to-Face Control Group | Active comparator | Participants in this arm received standard face-to-face counseling at the outpatient clinic at baseline, Day 10, Month 1, Month 2, Month 3, and Month 6. They also received standard pharmacological treatment (transdermal nicotine patches) and behavioral counseling (5A framework and motivational interviewing). Receives: Behavioral: Face-to-Face Counseling |
What is being measured
The primary outcome is the main question the study is designed to answer.
7-Day Point Prevalence Smoking Abstinence Rate
The proportion of participants who reported self-reported smoking abstinence (7-day point prevalence abstinence) confirmed during follow-up visits/consultations.
Measured: 6 months
Secondary outcomes (2)
Cigarette Craving Score
Total score, strength subscale, and frequency subscale scores measured using the Turkish version of the Craving Experience Questionnaire (CEQ). Total scores range from 0 to 200, with higher scores indicating higher intensity and frequency of craving.
Measured: Baseline, Day 10, Month 1, Month 2, Month 3, and Month 6
Medication Adherence
Assessment of medication adherence using the Turkish Modified Morisky Medication Adherence Scale
Measured: Day 10, Month 1, Month 2, and Month 3
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2026
- Study start1 Nov 2021
- Primary completion30 Aug 2022
- Study completion1 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tobacco Use DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A 1:1 open-label, parallel-group randomized controlled trial comparing video-based teleconsultation counseling with face-to-face counseling in a primary care smoking cessation clinic over a 6-month follow-up period.
- Masking
- None (open label)
- Enrolment
- 68 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dokuz Eylul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Oğulcan Çöme, Dokuz Eylul University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07737288
- Sponsor's protocol ID
- 21/19-13
- Status last verified
- Jul 2026
- First submitted
- 27 Jul 2026
- Last updated
- 30 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Teleconsultation Counseling in Smoking Cessation Treatment on Smoking Cessation Success: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07737288
- Acronym / sponsor ID
- 21/19-13
- Conditions
- Tobacco Use Disorder, Nicotine Dependence
- Keywords
- Teleconsultation, Telemedicine, Video Consultation, Smoking Cessation, Tobacco Dependence, Craving, Treatment Adherence
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 68 participants (actual)
- Lead sponsor
- Dokuz Eylul UniversityUniversity, hospital or other
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 30 Aug 2022 (actual)
- Study completion
- 1 Oct 2022 (actual)
- First posted
- 30 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial conducted at Dokuz Eylül University evaluated whether video teleconsultations are as effective as traditional face-to-face clinic visits for helping people quit smoking
- Over a 6-month period, the study found that while overall quit rates were statistically similar between the two groups, patients receiving teleconsultation support experienced significantly fewer cigarette cravings and fewer relapses
- Teleconsultation also solved a common problem in smoking cessation: patients missing their follow-up appointments due to travel or time constraints
Detailed description
Detailed Description Background \& Purpose of the Study Smoking is a leading cause of preventable diseases and death worldwide
- While many smokers want to quit, they often face barriers to attending regular follow-up appointments at clinics, such as transportation issues, travel costs, child care, and lack of time
- This study was designed to see if teleconsultation (video calling) could remove these barriers and provide an effective alternative to in-person visits for smoking cessation counseling
Who Participated? The study included 65 volunteer adults, aged 18 to 55, who applied to a smoking cessation clinic
- Participants were randomly divided into two groups: 32 people in the teleconsultation group and 33 people in the face-to-face (control) group
How the Study Worked Both groups received the standard of care recommended by the Ministry of Health . Initial Visit: Every participant had their first visit in person. They underwent a physical exam, had their health history taken, and received a prescription for nicotine replacement therapy (15 mg or 25 mg nicotine patches)
. Follow-Up Plan: After setting a "quit date," patients were followed up on day 10, and at months 1, 2, 3, and 6
. The Difference: The intervention group had all their follow-up counseling sessions via video teleconsultation, while the control group was asked to return to the clinic for face-to-face counseling
.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- A 1:1 open-label, parallel-group randomized controlled trial comparing video-based teleconsultation counseling with face-to-face counseling in a primary care smoking cessation clinic over a 6-month follow-up period.
| Arm | Type | Receives |
|---|---|---|
| Tele-consultation Group | Experimental | Behavioral: Tele-consultation CounselingParticipants in this arm received face-to-face counseling at the baseline visit, followed by 5 video-based teleconsultation sessions (at Day 10, Month 1, Month 2, Month 3, and Month 6). They also received standard pharmacological treatment (transdermal nicotine patches) and behavioral counseling (5A framework and motivational interviewing). |
| Face-to-Face Control Group | Active comparator | Behavioral: Face-to-Face CounselingParticipants in this arm received standard face-to-face counseling at the outpatient clinic at baseline, Day 10, Month 1, Month 2, Month 3, and Month 6. They also received standard pharmacological treatment (transdermal nicotine patches) and behavioral counseling (5A framework and motivational interviewing). |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Applying to Dokuz Eylul University Department of Family Medicine Smoking Cessation Outpatient Clinic
- Aged 18-55 years
- Owning and being able to use a personal computer or smartphone
- Being literate
- Voluntarily agreeing to participate in the study and providing written informed consent
Key exclusion criteria (4 listed)
- Having communication difficulties or severe cognitive impairments
- Having a psychotic disorder
- Being pregnant or breastfeeding
- Having received smoking cessation treatment within the past 1 year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Tele-consultation CounselingVideo-based teleconsultation counseling sessions focusing on smoking cessation, craving management, relapse prevention, and treatment adherence. | Behavioural | Tele-consultation Group |
| Face-to-Face CounselingStandard clinic-based face-to-face behavioral counseling sessions following the 5A framework and motivational interviewing. | Behavioural | Face-to-Face Control Group |
Primary outcome
7-Day Point Prevalence Smoking Abstinence Rate
Time frame: 6 months
The proportion of participants who reported self-reported smoking abstinence (7-day point prevalence abstinence) confirmed during follow-up visits/consultations.
2 secondary outcomes
Cigarette Craving Score
Time frame: Baseline, Day 10, Month 1, Month 2, Month 3, and Month 6
Medication Adherence
Time frame: Day 10, Month 1, Month 2, and Month 3
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Tobacco Use Disorder
Active, not recruiting
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
Recruiting
Effectiveness of Volitional Help Sheets as an Adjunct to Treatment to Promote Behavior Change: A Pilot Study on Smoking
Tobacco Dependence
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Recruiting
Young Adult Tobacco/Nicotine and Cannabis Co-use
Tobacco Use Disorder, Nicotine Dependence
RecruitingObservational study
Salivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers
Oral Potentially Malignant Disorders, Oral Lichen Planus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Tele-consultation Counseling and Face-to-Face Counseling in people with Tobacco Use Disorder and Nicotine Dependence, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
7-Day Point Prevalence Smoking Abstinence Rate (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2026.